SHIELD ILLINOIS SALIVA TEST


SHIELD Illinois is a screening testing program and infrastructure that deploys the University of Illinois’ innovative saliva test across the state.

The test has been validated, the University of Illinois System’s final application for emergency use authorization from the United States Food and Drug Administration was submitted on Dec. 30, 2020, and the FDA’s independent review of the validation is pending.

The test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing covered by a laboratory’s CLIA certification for high-complexity testing, and not for at home testing including at-home specimen collection.

INSTRUCTIONS FOR USE TEST PERFORMANCE CHARACTERISTICS SALIVA-BASED MOLECULAR TESTING FOR SARS-COV-2 THAT BYPASSES RNA EXTRACTION